Symptom-Targeted Rehabilitation for Concussion (STAR-C2)
Mild Traumatic Brain Injury
About this trial
This is an interventional treatment trial for Mild Traumatic Brain Injury focused on measuring Cognitive Rehabilitation, Cognitive Functioning
Eligibility Criteria
Inclusion Criteria:
- Is a community-dwelling Canadian Armed Forces veteran.
- Is age 18 years or older.
- Self-identifies as a fluent English speaker.
- Has no previous history of neurological disorder affecting cognition, by self-report.
- Is able to participate in rehabilitation for 4 weeks: 3 weeks of treatment + baseline + outcome assessment, with potential rescheduling for missed sessions.
- Is not actively participating in cognitive rehabilitation directed by a registered health professional (e.g., speech-language pathologist or occupational therapist).
- Has access to an electronic device with Zoom video platform capacity and internet access.
Exclusion Criteria:
- A score of less than 20 on the Montreal Cognitive Assessment (MoCA), which indicates a risk for dementia.
- Cannot identify at least 3 problems on the Common Cognitive Complaints after Concussion Questionnaire (C4), as there would be insufficient areas for intervention.
Sites / Locations
- McMaster UniversityRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
Therapy Group
Educational Group
The Therapy Group will receive 6-10 individual sessions of 30-60 minutes each, delivered by a trained Occupational Therapist or Speech-Language Pathologist. The therapy will be delivered over a 4-week timeframe, with the total number of sessions per participant depending on the number of sessions needed to achieve their treatment targets. Each participant in the Therapy Group will identify three cognitive targets for treatment. Progress in reaching those targets will be documented using Goal Attainment Scaling (GAS)
The education group will receive information about self-management of cognitive symptoms at the time of randomization, a common intervention for adults with mild Traumatic Brain Injury.